Measuring the sensitivity of COVID tests with new material from NIST

Researchers at the National Institute of Standards and Technology (NIST) have produced synthetic gene fragments from SARS-CoV-2, the virus that causes COVID-19. This material, which is non-infectious and safe to handle, can help manufacturers produce more accurate and reliable diagnostic tests for the disease. Tests for an active infection — as opposed to antibody tests…

Details

Virtual imaging trials optimize CT, radiography for coronavirus disease (COVID-19)

Leesburg, VA, August 25, 2020–An open-access article in ARRS’ American Journal of Roentgenology (AJR) established a foundation for the use of virtual imaging trials in effective assessment and optimization of CT and radiography acquisitions and analysis tools to help manage the coronavirus disease (COVID-19) pandemic. Virtual imaging trials have two main components–representative models of targeted…

Details